In human populations, CNTNAP2 heterozygous mutations do not always produce symptoms of ASD, while homozygous individuals for the mutation display ASD symptoms, along with epilepsy, facial dysmorphisms, severe intellectual disability and impaired language (Rodenas-Cuadrado et al., 2016). The gene discussed is CNTNAP2; the disease is epilepsy.